HCFWO
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Icahn School of Medicine at Mount Sinai
Overview
HCFWO is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
HCFWO clinical trials
Explore related
Medical disclaimer. This page summarizes research about HCFWO for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.